THE PERSONAL CARE PRODUCTS COUNCIL for PERSONAL CARE PRODUCTS COUNCIL
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
HR 2269/S 1092, WIPPES Act (product labeling for non-flushable wipes); H.R. 2853 / S. 1404,Combating Organized Retail Crime Act; H.R. 4433, Toxic-Free Beauty Act; H.R. 9594 No PFAS In Cosmetics Act; H.R. 6832, Packaging and Claims Knowledge (PACK) Act of 2025; H.R. 7205Recycled Materials Attributions Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Animals ANI
HR 1657, Humane Cosmetics Act; H.R. 2821/S. 355, FDA Modernization Act 3.0 (issues related to animal-based testing for OTC products); Adoption of non-animal test methods/New Approach Methodologies (NAMs)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE BAILEY | — |
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Budget/Appropriations BUD
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (cosmetic regulation funding issues); Fiscal Year 2027 Appropriations package (funding for the Department of Defense's Melanoma Research Program).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE BAILEY | — |
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Health Issues HCR
Over-the-Counter Monograph User Fees (issues related to the OMUFA program); Implementation of provision from the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE BAILEY | — |
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Tariff (miscellaneous tariff bills) TAR
Section 301, Section 232 and IEEPA Tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATALIE OBERMANN | — |
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Copyright/Patent/Trademark CPT
SHOP SAFE Act (issues related to counterfeit cosmetic products); H.R. 4390: To expand the sharing of information with respect to suspected violations of intellectual property rights in trade (issues related to counterfeit cosmetic products).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Trade (domestic/foreign) TRD
US Mexico Canada Agreement Review; Trade issues with China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NATALIE OBERMANN | — |
| KARIN ROSS | — |
| GENEVIEVE STRAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.